Form 4: Sight Sciences CTO Sells Shares for Tax Liability

Sight Sciences' Chief Technology Officer, David Badawi, sold 4,836 shares of common stock on January 16, 2026, at a weighted average price of $6.62 per share to cover tax liabilities from restricted stock unit vesting.

Summary

• David Badawi, Chief Technology Officer and Director of Sight Sciences, Inc. (SGHT), reported a sale of common stock.
• The transaction involved the disposition of 4,836 shares of common stock on January 16, 2026.
• The shares were sold at a weighted average price of $6.62 per share, with prices ranging from $6.44 to $6.69.
• The sale was conducted to cover the reporting person's tax liability associated with the vesting of restricted stock units (RSUs).
• The transaction was made pursuant to a Rule 10b5-1(c) contract, instruction, or written plan.
• Following this transaction, David Badawi beneficially owns 1,912,273 shares, which includes 1,774,250 shares of common stock and 138,023 unvested restricted stock units.

Sentiment

Score: 5

Explanation: The sentiment is neutral as this is a routine, pre-scheduled insider transaction for tax purposes related to RSU vesting, which is a common occurrence and does not reflect a change in the company's fundamentals or the executive's confidence.

Positives

• The transaction was pre-scheduled under a Rule 10b5-1(c) plan, indicating a planned and transparent sale rather than a discretionary one based on new information.
• The sale was for tax liability purposes related to RSU vesting, which is a routine event for executives receiving equity compensation.

Negatives

• An insider sale, even for tax purposes, can sometimes be perceived negatively by the market, though this is a common and expected event for executives.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

This Form 4 filing details a routine insider transaction for tax purposes, which is common across all industries for executives receiving equity compensation. It does not provide information directly related to broader industry trends or competitive landscape.

Corporate Governance

Stakeholder Impact

• Shareholders: Minimal direct impact as this is a routine, pre-scheduled transaction for tax purposes and does not signal a change in the company's operational or financial health.
• Employees: No direct impact mentioned.

Key Dates

Recommendation

This Form 4 filing reports a routine, pre-scheduled sale of shares by an executive to cover tax liabilities associated with RSU vesting. Such transactions are common and do not typically indicate a change in the company's fundamental outlook or the executive's long-term confidence. Therefore, it provides no new information that would warrant a change in investment thesis, leading to a 'hold' recommendation.

Keywords

Sight Sciences, SGHT, Insider Transaction, Form 4, Stock Sale, Executive Compensation, RSU Vesting, Tax Liability, David Badawi, Chief Technology Officer